SEC 13F Intelligence

Barrow Hanley Mewhinney & Strauss LLC / ELV

Barrow Hanley Mewhinney & Strauss LLC’s Elevance Health Inc Formerly Position

Does Barrow Hanley Mewhinney & Strauss LLC own Elevance Health Inc Formerly (ELV)? Yes — 407.2K shares worth $119M (+0.39% of its 13F portfolio) as of Q1 2026, down from 505.5K shares the prior filed quarter.

Position Value
$119M
Q1 2026
Shares
407.2K
% of Portfolio
+0.39%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $537MQ4 ’18Q1 ’19: $545MQ2 ’19: $1.1BQ3 ’19: $868MQ4 ’19: $517MQ4 ’19Q1 ’20: $409MQ2 ’20: $423MQ3 ’20: $421MQ4 ’20: $486MQ4 ’20Q1 ’21: $592MQ2 ’21: $692MQ3 ’21: $687MQ4 ’21: $812MQ4 ’21Q1 ’22: $806MQ2 ’22: $779MQ3 ’22: $685MQ4 ’22: $745MQ4 ’22Q1 ’23: $585MQ2 ’23: $550MQ3 ’23: $597MQ4 ’23: $645MQ4 ’23Q1 ’24: $660MQ2 ’24: $668MQ3 ’24: $442MQ4 ’24: $289MQ4 ’24Q1 ’25: $553MQ2 ’25: $226MQ3 ’25: $161MQ4 ’25: $177MQ4 ’25Q1 ’26: $119Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026407.2K$119M+0.39%
Q4 2025505.5K$177M+0.59%
Q3 2025497.3K$161M+0.51%
Q2 2025581.2K$226M+0.76%
Q1 20251.27M$553M+2.01%
Q4 2024782.9K$289M+0.98%
Q3 2024850.6K$442M+1.45%
Q2 20241.23M$668M+2.28%
Q1 20241.27M$660M+2.22%
Q4 20231.37M$645M+2.27%
Q3 20231.37M$597M+2.28%
Q2 20231.24M$550M+2.05%
Q1 20231.27M$585M+2.26%
Q4 20221.45M$745M+2.80%
Q3 20221.51M$685M+2.81%
Q2 20221.61M$779M+2.94%
Q1 20221.64M$806M+2.63%
Q4 20211.75M$812M+2.57%
Q3 20211.84M$687M+2.28%
Q2 20211.81M$692M+2.22%
Q1 20211.65M$592M+1.88%
Q4 20201.51M$486M+1.67%
Q3 20201.57M$421M+1.62%
Q2 20201.61M$423M+1.66%
Q1 20201.80M$409M+1.87%
Q4 20191.71M$517M+1.65%
Q3 20193.62M$868M+1.70%
Q2 20193.82M$1.1B+1.96%
Q1 20191.90M$545M+0.98%
Q4 20182.04M$537M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Barrow Hanley Mewhinney & Strauss LLC’s full portfolio or all institutional holders of ELV.